Table 2.
Subtypes of MC | Immunological profile |
Genetic predisposition | References | |||||
---|---|---|---|---|---|---|---|---|
Chemokine and receptor | Cytokine | Prostaglandin | Growth factor | T-lymphocyte | Others | |||
CC and LC | ↑: CXCL8, CXCL9, CXCL10, CXCL11, CCL2, CCL3, CCL20, CX3CL1, CX3CL2, CXCR1, CXCR2 | ↑: TNF-α mRNA, IFN-γ mRNA, IL-17-A mRNA, IL-10, IL-21, IL-23 | ↑: COX-2 | – | ↑: Th1/Tc1, Th17/Tc17, Ki67+ T, CD45RO+ T, FoxP3+ Treg | ↓: TRECs | – | [10, 39–42] |
CC | ↑: CXCR3, CX3CR1, CCR3, CCR5, CCR7, CCR8, CCR10 | ↑: IL-6 | – | ↑: VEGF, CTGF, TGF-β1, bFGF | – | ↑: TIMP1, CfB, miR-31, T-bet | HLA haplotype 8.1 | [10, 28, 39, 40, 42, 43] |
↓: CXCL5, CXCL7, CXCL8, CXCL9, CXCL12, CXCL13, XCL1, CCL7, CCL8, CCL16 | ||||||||
LC | ↑: CXCL11, CXCL8, CCL3, CCL5 | ↑: IL-15 mRNA | – | – | ↓: CD4+T, CD4+CD8+T, CD4-CD8-T; | ↑: T-bet/GATA-3. | – | [10, 42] |
↑: CD8+T, CD4+γδ +T | ↓: TcRβ V-J: eveness, diversity |
↑: increased indicator level; ↓: decreased indicator level; –, not mentioned; CC, collagenous colitis; LC, lymphocytic colitis; MC, microscopic colitis; CXCL, C-X-C motif chemokine ligand; CCL, chemokine c-c motif ligand; CX3CL, C-X-3-C motif chemokine ligand; CXCR, C-X-C motif chemokine receptor; TNF, tumor necrosis factor; IFN, interferon; IL, interleukin; COX, cyclooxygenases; Th, helper T-cell; CD, Cluster of Differentiation; FoxP3, forkhead box protein P3; Treg, regulatory T-cell; TREC, T-cell receptor excision circle; CX3CR, C-X-3-C motif chemokine receptor; CCR, C-C chemokine receptor; XCL, X-C motif chemokine ligand; VEGF, vascular endothelial growth factor; CTGF, connective tissue growth factor; TGF, transforming growth factor; bFGF, basic fibroblast growth factor; TIMP, tissue inhibitor of metalloproteinase; CfB, complement factor B; miR, miRNA; HLA, human leukocyte antigen; T-bet, T-box transcription factor; GATA, a class of transcriptional regulators that normally recognize the consensus sequence WGATAR (W = T or A; R = G or A); TcRβ V-J, T-cell antigen receptor beta chain variable-J.